Australia's Murdoch University and Epichem, a partnering medicinal chemistry company, received $3 million from the Drugs for Neglected Diseases Initiative, a global, collaborative nonprofit, to boost its Chagas' disease research program. The university's Parasitology Research Group will lead the research and will be the only center in the southern hemisphere screening drugs against the major diseases transmitted through vectors.

Related Summaries